top of page

How Semaglutide Works for Weight Loss

In the dynamic landscape of weight management, Semaglutide has emerged as a promising solution, initially developed for type 2 diabetes but gaining recognition for its significant impact on weight reduction. In this blog post, we will take a closer look at what Semaglutide is all about, covering its procedure, mechanism of action, administration, results, risks, responsible use, indications, contraindications, and crucial warnings and precautions.

How It Works:

  1. GLP-1 Receptor Activation: Semaglutide stimulates the GLP-1 receptors present in various tissues throughout the body, primarily in the pancreas and the gastrointestinal tract.

  2. Blood Sugar Regulation: By activating GLP-1 receptors in the pancreas, Semaglutide enhances insulin secretion in response to elevated blood sugar levels. This helps regulate blood glucose levels, reducing the risk of hyperglycemia.

  3. Appetite Suppression: GLP-1 receptors are also present in the brain, particularly in the hypothalamus—the region responsible for regulating appetite. When activated, these receptors induce a feeling of fullness or satiety, reducing appetite and promoting weight loss.

  4. Slowing Stomach Emptying: Semaglutide affects the rate at which the stomach empties its contents into the small intestine. By slowing down stomach emptying, the medication contributes to prolonged feelings of fullness, further reducing the desire to eat.

  5. Inhibition of Glucagon Release: GLP-1 receptor activation inhibits the release of glucagon, a hormone that raises blood sugar levels by promoting the breakdown of stored glucose in the liver. By suppressing glucagon, Semaglutide helps maintain blood sugar levels within a healthy range.

  6. Reduction of Liver Fat: GLP-1 receptor activation in the liver leads to a reduction in the accumulation of fat. This effect is particularly beneficial for individuals with non-alcoholic fatty liver disease (NAFLD) or other liver-related conditions.


Semaglutide's administration involves injections, commonly targeted at the arm, thigh or abdomen. Clear instructions accompany pre-filled syringes or vials, making self-administration straightforward. Regular consultations with healthcare professionals is important for progress monitoring, addressing concerns, and potential dosage adjustments.


Noteworthy weight loss is often observed within the initial weeks of Semaglutide use. Clinical trials substantiate these claims, showcasing significant, sustained weight reduction. The medication's systemic approach makes it an appealing choice for those struggling with obesity.

Risks or Side Effects:

  1. Nausea

  2. Vomiting

  3. Diarrhea or Constipation

  4. Headaches

  5. Upset Stomach

  6. Heartburn

These side effects occur particularly during the initial weeks of use.

In rare cases, adverse reactions may include pancreatitis, gallstones, low blood sugar (hypoglycemia), kidney problems including kidney failure, changes in vision in people with type 2 diabetes, increased resting heart rate, depression or thoughts of suicide.

If you experience any severe side effects, consultation with a healthcare professional is crucial.

Important Information on Responsible Use:

Responsible Semaglutide use involves strict adherence to prescribed dosages and healthcare provider guidelines. Regular check-ups facilitate progress monitoring and timely addressing of concerns. Users must communicate any pre-existing medical conditions, medications, or allergies to ensure safe and effective use.

Indications and Usage:

Semaglutide is indicated for chronic weight management in adults with a BMI of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater with at least one weight-related comorbidity. It is not intended for use in type 1 diabetes and is contraindicated in certain populations.


  1. Medullary Thyroid Carcinoma (MTC): MTC is a rare but aggressive form of thyroid cancer. Semaglutide is contraindicated in individuals with a personal or family history of MTC due to the potential risk of exacerbating or triggering the condition. Activation of GLP-1 receptors, which Semaglutide induces, may stimulate the growth of MTC.

  2. Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2):  MEN 2 is a genetic disorder associated with an increased risk of developing MTC. Semaglutide is contraindicated in individuals with MEN 2 due to the elevated risk of MTC development.

  3. Hypersensitivity: Semaglutide should not be used in individuals with a history of severe hypersensitivity reactions to the medication or any of its components. Hypersensitivity reactions can range from mild skin reactions to severe anaphylaxis, necessitating immediate medical attention.

Warnings and Precautions:

  1. Pancreatitis: In clinical trials, cases of acute pancreatitis were reported, although the incidence was low. Individuals with a history of pancreatitis or those prone to pancreatitis should exercise caution, and Semaglutide should be discontinued if pancreatitis is suspected.

  2. Cardiovascular Disease: While Semaglutide has shown cardiovascular safety in clinical trials, caution is advised due to the potential effects on heart rate and blood pressure. Close monitoring is recommended in individuals with a history of cardiovascular disease.

  3. Diabetic Ketoacidosis: Semaglutide is not indicated for the treatment of diabetic ketoacidosis (DKA). Individuals with type 1 diabetes or those with poorly controlled type 2 diabetes who are at risk of DKA should avoid Semaglutide. Using Semaglutide in such conditions may exacerbate the risk of ketoacidosis.

  4. Renal Impairment: Individuals with renal impairment may require dosage adjustments when using Semaglutide. As the medication is excreted through the kidneys, impaired renal function can affect its elimination. Close monitoring and appropriate dosage adjustments are crucial to ensure the safe and effective use of Semaglutide in individuals with renal impairment.

Semaglutide stands as a beacon in the realm of weight management, offering a holistic approach to achieving and maintaining a healthy weight. This comprehensive guide aims to empower individuals with the knowledge necessary for an informed decision, emphasizing responsible use under the guidance of healthcare professionals.

22 views0 comments


Bodies of Atlanta

2752 E Ponce De Leon Ave Suite E Decatur GA 30030

Phone: 404-263-4245

bottom of page